» Articles » PMID: 32100971

Expanding the Spectrum of SMAD3-related Phenotypes to Agnathia-otocephaly

Overview
Specialty Genetics
Date 2020 Feb 27
PMID 32100971
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Agnathia-otocephaly is a rare and lethal anomaly affecting craniofacial structures derived from the first pharyngeal arch. It is characterized by agnathia, microstomia, aglossia, and abnormally positioned auricles with or without associated anomalies. Variants affecting function of OTX2 and PRRX1, which together regulate the neural crest cells and the patterning of the first pharyngeal arch as well as skeletal and limb development, were identified to be causal for the anomaly in a few patients.

Methods: Family-based exome sequencing (ES) on a fetus with severe agnathia-otocephaly, cheilognathopalatoschisis, laryngeal hypoplasia, fused lung lobes and other organ abnormalities and mRNA expression analysis were performed.

Results: Exome sequencing detected a de novo SMAD3 missense variant in exon 6 (c.860G>A) associated with decreased mRNA expression. Variants in SMAD3 cause Loeys-Dietz syndrome 3 presenting with craniofacial anomalies such as mandibular hypoplasia, micro- or retro-gnathia, bifid uvula and cleft palate as well as skeletal anomalies and arterial tortuosity. The SMAD3 protein acts as a transcriptional regulator in the transforming growth factor β (TGFB) and bone morphogenetic (BMP) signaling pathways, which play a key role in the development of craniofacial structures originating from the pharyngeal arches.

Conclusion: Agnathia-otocephaly with or without associated anomalies may represent the severe end of a phenotypic spectrum related to variants in genes in the interacting SMAD/TGFB/BMP/SHH/FGF developmental pathways.

Citing Articles

Expanding the spectrum of SMAD3-related phenotypes to agnathia-otocephaly.

Meier N, Bruder E, Miny P, Tercanli S, Filges I Mol Genet Genomic Med. 2020; 8(4):e1178.

PMID: 32100971 PMC: 7196462. DOI: 10.1002/mgg3.1178.

References
1.
Opitz J, Zanni G, Reynolds Jr J, Gilbert-Barness E . Defects of blastogenesis. Am J Med Genet. 2002; 115(4):269-86. DOI: 10.1002/ajmg.10983. View

2.
Rahman M, Akhtar N, Jamil H, Banik R, Asaduzzaman S . TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Res. 2015; 3:15005. PMC: 4472151. DOI: 10.1038/boneres.2015.5. View

3.
Gekas J, Li B, Kamnasaran D . Current perspectives on the etiology of agnathia-otocephaly. Eur J Med Genet. 2010; 53(6):358-66. DOI: 10.1016/j.ejmg.2010.09.002. View

4.
Yang X, Letterio J, Lechleider R, Chen L, Hayman R, Gu H . Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J. 1999; 18(5):1280-91. PMC: 1171218. DOI: 10.1093/emboj/18.5.1280. View

5.
Massague J . TGFβ signalling in context. Nat Rev Mol Cell Biol. 2012; 13(10):616-30. PMC: 4027049. DOI: 10.1038/nrm3434. View